Filing Details
- Accession Number:
- 0001209191-20-050277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-14 16:19:44
- Reporting Period:
- 2020-09-10
- Accepted Time:
- 2020-09-14 16:19:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1736295 | E Maria Pasquale | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-10 | 2,193 | $65.36 | 30,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-10 | 2,193 | $90.83 | 28,204 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-09-11 | 127 | $65.36 | 28,331 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2020-09-10 | 2,193 | $0.00 | 2,193 | $65.36 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-09-11 | 127 | $0.00 | 127 | $65.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,865 | 2028-04-09 | No | 4 | M | Direct | |
| 3,441 | 2028-04-09 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- This includes an aggregate of 22,552 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Billionaire Hedge Funds
